
Pubmed-entry ::= {
  pmid 19008416,
  medent {
    em std {
      year 2008,
      month 12,
      day 16
    },
    cit {
      title {
        name "Genomic loss of microRNA-101 leads to overexpression of histone
 methyltransferase EZH2 in cancer."
      },
      authors {
        names std {
          {
            name ml "Varambally S",
            affil str "Michigan Center for Translational Pathology, University
 of Michigan Medical School, Ann Arbor, MI 48109, USA."
          },
          {
            name ml "Cao Q"
          },
          {
            name ml "Mani RS"
          },
          {
            name ml "Shankar S"
          },
          {
            name ml "Wang X"
          },
          {
            name ml "Ateeq B"
          },
          {
            name ml "Laxman B"
          },
          {
            name ml "Cao X"
          },
          {
            name ml "Jing X"
          },
          {
            name ml "Ramnarayanan K"
          },
          {
            name ml "Brenner JC"
          },
          {
            name ml "Yu J"
          },
          {
            name ml "Kim JH"
          },
          {
            name ml "Han B"
          },
          {
            name ml "Tan P"
          },
          {
            name ml "Kumar-Sinha C"
          },
          {
            name ml "Lonigro RJ"
          },
          {
            name ml "Palanisamy N"
          },
          {
            name ml "Maher CA"
          },
          {
            name ml "Chinnaiyan AM"
          }
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 12,
            day 12
          },
          volume "322",
          issue "5908",
          pages "1695-1699",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus aheadofprint,
              date std {
                year 2008,
                month 11,
                day 13
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 11,
                day 15,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 11,
                day 15,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2009,
                month 1,
                day 6,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "1165395",
        doi "10.1126/science.1165395",
        pubmed 19008416,
        other {
          db "pmc",
          tag str "PMC2684823"
        },
        other {
          db "mid",
          tag str "NIHMS104414"
        },
        other {
          db "ELocationID doi",
          tag str "10.1126/science.1165395"
        }
      }
    },
    abstract "Enhancer of zeste homolog 2 (EZH2) is a mammalian histone
 methyltransferase that contributes to the epigenetic silencing of target
 genes and regulates the survival and metastasis of cancer cells. EZH2 is
 overexpressed in aggressive solid tumors by mechanisms that remain unclear.
 Here we show that the expression and function of EZH2 in cancer cell lines
 are inhibited by microRNA-101 (miR-101). Analysis of human prostate tumors
 revealed that miR-101 expression decreases during cancer progression,
 paralleling an increase in EZH2 expression. One or both of the two genomic
 loci encoding miR-101 were somatically lost in 37.5% of clinically localized
 prostate cancer cells (6 of 16) and 66.7% of metastatic disease cells (22 of
 33). We propose that the genomic loss of miR-101 in cancer leads to
 overexpression of EZH2 and concomitant dysregulation of epigenetic pathways,
 resulting in cancer progression.",
    mesh {
      {
        term "3' Untranslated Regions"
      },
      {
        term "Algorithms"
      },
      {
        term "Breast Neoplasms",
        qual {
          {
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Cell Line, Tumor"
      },
      {
        term "DNA-Binding Proteins",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Disease Progression"
      },
      {
        term "Epigenesis, Genetic"
      },
      {
        term "Female"
      },
      {
        mp TRUE,
        term "Gene Expression Regulation, Neoplastic"
      },
      {
        term "Genome, Human"
      },
      {
        term "Histones",
        qual {
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "Lysine",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Male"
      },
      {
        term "Methylation"
      },
      {
        term "MicroRNAs",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Neoplasm Metastasis"
      },
      {
        term "Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Polycomb Repressive Complex 2"
      },
      {
        term "Promoter Regions, Genetic"
      },
      {
        term "Prostatic Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "RNA, Small Interfering",
        qual {
          {
            subh "genetics"
          }
        }
      },
      {
        term "Stomach Neoplasms",
        qual {
          {
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Transcription Factors",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "metabolism"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "3' Untranslated Regions"
      },
      {
        type nameonly,
        name "DNA-Binding Proteins"
      },
      {
        type nameonly,
        name "Histones"
      },
      {
        type nameonly,
        name "MIRN101 microRNA, human"
      },
      {
        type nameonly,
        name "MicroRNAs"
      },
      {
        type nameonly,
        name "RNA, Small Interfering"
      },
      {
        type nameonly,
        name "Transcription Factors"
      },
      {
        type ec,
        cit "2.1.1.43",
        name "EZH2 protein, human"
      },
      {
        type ec,
        cit "2.1.1.43",
        name "Polycomb Repressive Complex 2"
      },
      {
        type cas,
        cit "K3Z4F929H6",
        name "Lysine"
      }
    },
    xref {
    },
    idnum {
      "K99 CA129565/CA/NCI NIH HHS",
      "K99 CA129565-01A1/CA/NCI NIH HHS",
      "P50 CA069568/CA/NCI NIH HHS",
      "P50 CA069568-06A10016/CA/NCI NIH HHS",
      "P50CA69568/CA/NCI NIH HHS",
      "U01 CA111275/CA/NCI NIH HHS",
      "U01 CA111275-04/CA/NCI NIH HHS",
      "UO1 111275/PHS HHS"
    },
    pmid 19008416,
    pub-type {
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    },
    status medline
  }
}



Pubmed-entry ::= {
  pmid 18927361,
  medent {
    em std {
      year 2008,
      month 10,
      day 17
    },
    cit {
      title {
        name "Genetics. DNA test for breast cancer risk draws criticism."
      },
      authors {
        names ml {
          "Couzin J"
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 10,
            day 17
          },
          volume "322",
          issue "5900",
          pages "357",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 10,
                day 18,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2008,
                month 11,
                day 4,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 10,
                day 18,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "322/5900/357",
        doi "10.1126/science.322.5900.357",
        pubmed 18927361,
        other {
          db "ELocationID doi",
          tag str "10.1126/science.322.5900.357"
        }
      }
    },
    mesh {
      {
        term "Breast Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          }
        }
      },
      {
        term "Female"
      },
      {
        mp TRUE,
        term "Genetic Predisposition to Disease"
      },
      {
        mp TRUE,
        term "Genetic Testing"
      },
      {
        term "Humans"
      },
      {
        term "Polymorphism, Single Nucleotide"
      }
    },
    pmid 18927361,
    pub-type {
      "News"
    },
    status medline
  }
}



Pubmed-entry ::= {
  pmid 18787170,
  medent {
    em std {
      year 2008,
      month 9,
      day 12
    },
    cit {
      title {
        name "FBXW7 targets mTOR for degradation and cooperates with PTEN in
 tumor suppression."
      },
      authors {
        names std {
          {
            name ml "Mao JH",
            affil str "Cancer Research Institute, University of California at
 San Francisco, 2340 Sutter Street, San Francisco, CA 94143, USA."
          },
          {
            name ml "Kim IJ"
          },
          {
            name ml "Wu D"
          },
          {
            name ml "Climent J"
          },
          {
            name ml "Kang HC"
          },
          {
            name ml "DelRosario R"
          },
          {
            name ml "Balmain A"
          }
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 9,
            day 12
          },
          volume "321",
          issue "5895",
          pages "1499-1502",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 9,
                day 13,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2008,
                month 9,
                day 26,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 9,
                day 13,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "321/5895/1499",
        doi "10.1126/science.1162981",
        pubmed 18787170,
        other {
          db "pmc",
          tag str "PMC2849753"
        },
        other {
          db "mid",
          tag str "NIHMS132604"
        },
        other {
          db "ELocationID doi",
          tag str "10.1126/science.1162981"
        }
      }
    },
    abstract "The enzyme mTOR (mammalian target of rapamycin) is a major
 target for therapeutic intervention to treat many human diseases, including
 cancer, but very little is known about the processes that control levels of
 mTOR protein. Here, we show that mTOR is targeted for ubiquitination and
 consequent degradation by binding to the tumor suppressor protein FBXW7.
 Human breast cancer cell lines and primary tumors showed a reciprocal
 relation between loss of FBXW7 and deletion or mutation of PTEN (phosphatase
 and tensin homolog), which also activates mTOR. Tumor cell lines harboring
 deletions or mutations in FBXW7 are particularly sensitive to rapamycin
 treatment, which suggests that loss of FBXW7 may be a biomarker for human
 cancers susceptible to treatment with inhibitors of the mTOR pathway.",
    mesh {
      {
        term "Animals"
      },
      {
        term "Breast Neoplasms",
        qual {
          {
            subh "drug therapy"
          },
          {
            subh "genetics"
          },
          {
            mp TRUE,
            subh "metabolism"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Cell Cycle Proteins",
        qual {
          {
            subh "genetics"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Cell Line"
      },
      {
        term "Cell Line, Tumor"
      },
      {
        term "F-Box Proteins",
        qual {
          {
            subh "genetics"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Gene Deletion"
      },
      {
        term "Gene Dosage"
      },
      {
        term "Gene Silencing"
      },
      {
        term "Genes, Tumor Suppressor"
      },
      {
        term "Humans"
      },
      {
        term "Mice"
      },
      {
        term "Mice, Nude"
      },
      {
        term "Mutation"
      },
      {
        term "Neoplasm Transplantation"
      },
      {
        term "PTEN Phosphohydrolase",
        qual {
          {
            subh "genetics"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Phosphorylation"
      },
      {
        term "Protein Binding"
      },
      {
        term "Protein Kinases",
        qual {
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Proto-Oncogene Proteins c-akt",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Signal Transduction"
      },
      {
        term "Sirolimus",
        qual {
          {
            subh "pharmacology"
          },
          {
            subh "therapeutic use"
          }
        }
      },
      {
        term "TOR Serine-Threonine Kinases"
      },
      {
        term "Transfection"
      },
      {
        term "Tumor Suppressor Proteins",
        qual {
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Ubiquitin-Protein Ligases",
        qual {
          {
            subh "genetics"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Ubiquitination"
      }
    },
    substance {
      {
        type nameonly,
        name "Cell Cycle Proteins"
      },
      {
        type nameonly,
        name "F-Box Proteins"
      },
      {
        type nameonly,
        name "Tumor Suppressor Proteins"
      },
      {
        type ec,
        cit "2.7.-",
        name "Protein Kinases"
      },
      {
        type ec,
        cit "2.7.1.1",
        name "MTOR protein, human"
      },
      {
        type ec,
        cit "2.7.1.1",
        name "TOR Serine-Threonine Kinases"
      },
      {
        type ec,
        cit "2.7.1.1",
        name "mTOR protein, mouse"
      },
      {
        type ec,
        cit "2.7.11.1",
        name "Proto-Oncogene Proteins c-akt"
      },
      {
        type ec,
        cit "3.1.3.48",
        name "PTEN protein, human"
      },
      {
        type ec,
        cit "3.1.3.67",
        name "PTEN Phosphohydrolase"
      },
      {
        type ec,
        cit "6.3.2.19",
        name "FBXW7 protein, human"
      },
      {
        type ec,
        cit "6.3.2.19",
        name "Ubiquitin-Protein Ligases"
      },
      {
        type cas,
        cit "W36ZG6FT64",
        name "Sirolimus"
      }
    },
    idnum {
      "R01 CA116481/CA/NCI NIH HHS",
      "U01 CA084244/CA/NCI NIH HHS",
      "U01 CA084244-08/CA/NCI NIH HHS",
      "U01 CA084244-09/CA/NCI NIH HHS",
      "U01 CA084244-10/CA/NCI NIH HHS"
    },
    pmid 18787170,
    pub-type {
      "Journal Article"
    },
    status medline
  }
}



Pubmed-entry ::= {
  pmid 18487186,
  medent {
    em std {
      year 2008,
      month 5,
      day 19
    },
    cit {
      title {
        name "Design logic of a cannabinoid receptor signaling network that
 triggers neurite outgrowth."
      },
      authors {
        names std {
          {
            name ml "Bromberg KD",
            affil str "Department of Pharmacology and Systems Therapeutics,
 Mount Sinai School of Medicine, New York, NY 10029, USA."
          },
          {
            name ml "Ma'ayan A"
          },
          {
            name ml "Neves SR"
          },
          {
            name ml "Iyengar R"
          }
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 5,
            day 16
          },
          volume "320",
          issue "5878",
          pages "903-909",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 5,
                day 20,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2008,
                month 5,
                day 28,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 5,
                day 20,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "320/5878/903",
        doi "10.1126/science.1152662",
        pubmed 18487186,
        other {
          db "pmc",
          tag str "PMC2776723"
        },
        other {
          db "mid",
          tag str "NIHMS142954"
        },
        other {
          db "ELocationID doi",
          tag str "10.1126/science.1152662"
        }
      }
    },
    abstract "Cannabinoid receptor 1 (CB1R) regulates neuronal
 differentiation. To understand the logic underlying decision-making in the
 signaling network controlling CB1R-induced neurite outgrowth, we profiled the
 activation of several hundred transcription factors after cell stimulation.
 We assembled an in silico signaling network by connecting CB1R to 23
 activated transcription factors. Statistical analyses of this network
 predicted a role for the breast cancer 1 protein BRCA1 in neuronal
 differentiation and a new pathway from CB1R through phosphoinositol 3-kinase
 to the transcription factor paired box 6 (PAX6). Both predictions were
 experimentally confirmed. Results of transcription factor activation
 experiments that used pharmacological inhibitors of kinases revealed a
 network organization of partial OR gates regulating kinases stacked above AND
 gates that control transcription factors, which together allow for
 distributed decision-making in CB1R-induced neurite outgrowth.",
    mesh {
      {
        term "Animals"
      },
      {
        term "BRCA1 Protein",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Cell Differentiation"
      },
      {
        term "Cell Line, Tumor"
      },
      {
        term "Cells, Cultured"
      },
      {
        term "Computational Biology"
      },
      {
        term "Computer Simulation"
      },
      {
        term "Eye Proteins",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Hippocampus",
        qual {
          {
            subh "cytology"
          }
        }
      },
      {
        term "Homeodomain Proteins",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Metabolic Networks and Pathways"
      },
      {
        term "Mice"
      },
      {
        term "Neurites",
        qual {
          {
            mp TRUE,
            subh "physiology"
          }
        }
      },
      {
        term "Neurons",
        qual {
          {
            mp TRUE,
            subh "cytology"
          },
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Paired Box Transcription Factors",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Phosphatidylinositol 3-Kinases",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        term "Protein Interaction Mapping"
      },
      {
        term "Rats"
      },
      {
        term "Receptor, Cannabinoid, CB1",
        qual {
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Repressor Proteins",
        qual {
          {
            subh "metabolism"
          }
        }
      },
      {
        mp TRUE,
        term "Signal Transduction"
      },
      {
        term "Transcription Factors",
        qual {
          {
            subh "antagonists & inhibitors"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "BRCA1 Protein"
      },
      {
        type nameonly,
        name "Eye Proteins"
      },
      {
        type nameonly,
        name "Homeodomain Proteins"
      },
      {
        type nameonly,
        name "PAX6 protein"
      },
      {
        type nameonly,
        name "Paired Box Transcription Factors"
      },
      {
        type nameonly,
        name "Receptor, Cannabinoid, CB1"
      },
      {
        type nameonly,
        name "Repressor Proteins"
      },
      {
        type nameonly,
        name "Transcription Factors"
      },
      {
        type ec,
        cit "2.7.1.-",
        name "Phosphatidylinositol 3-Kinases"
      }
    },
    idnum {
      "1 S10 RR0 9145-01/RR/NCRR NIH HHS",
      "5R24 CA095823-04/CA/NCI NIH HHS",
      "GM072853/GM/NIGMS NIH HHS",
      "GM54508/GM/NIGMS NIH HHS",
      "P50 GM071558/GM/NIGMS NIH HHS",
      "P50 GM071558-01A2/GM/NIGMS NIH HHS",
      "P50 GM071558-01A20007/GM/NIGMS NIH HHS",
      "P50 GM071558-02/GM/NIGMS NIH HHS",
      "P50 GM071558-020007/GM/NIGMS NIH HHS",
      "P50 GM071558-030007/GM/NIGMS NIH HHS",
      "P50-071558/PHS HHS",
      "R01 GM054508/GM/NIGMS NIH HHS",
      "R01 GM054508-21/GM/NIGMS NIH HHS",
      "R01 GM072853/GM/NIGMS NIH HHS",
      "R01 GM072853-04/GM/NIGMS NIH HHS",
      "T32 CA88796/CA/NCI NIH HHS"
    },
    pmid 18487186,
    pub-type {
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, U.S. Gov't, Non-P.H.S."
    },
    status medline
  }
}



Pubmed-entry ::= {
  pmid 18239126,
  medent {
    em std {
      year 2008,
      month 2,
      day 1
    },
    cit {
      title {
        name "Cancer proliferation gene discovery through functional genomics."
      },
      authors {
        names std {
          {
            name ml "Schlabach MR",
            affil str "Howard Hughes Medical Institute and Department of
 Genetics, Center for Genetics and Genomics, Brigham and Women's Hospital,
 Harvard Medical School, Boston, MA 02115, USA."
          },
          {
            name ml "Luo J"
          },
          {
            name ml "Solimini NL"
          },
          {
            name ml "Hu G"
          },
          {
            name ml "Xu Q"
          },
          {
            name ml "Li MZ"
          },
          {
            name ml "Zhao Z"
          },
          {
            name ml "Smogorzewska A"
          },
          {
            name ml "Sowa ME"
          },
          {
            name ml "Ang XL"
          },
          {
            name ml "Westbrook TF"
          },
          {
            name ml "Liang AC"
          },
          {
            name ml "Chang K"
          },
          {
            name ml "Hackett JA"
          },
          {
            name ml "Harper JW"
          },
          {
            name ml "Hannon GJ"
          },
          {
            name ml "Elledge SJ"
          }
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 2,
            day 1
          },
          volume "319",
          issue "5863",
          pages "620-624",
          language "eng",
          retract {
            type in-error,
            exp "Science.2008 Apr 18;320(5874):316"
          },
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 2,
                day 2,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2008,
                month 2,
                day 13,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 2,
                day 2,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "319/5863/620",
        doi "10.1126/science.1149200",
        pubmed 18239126,
        other {
          db "pmc",
          tag str "PMC2981870"
        },
        other {
          db "mid",
          tag str "NIHMS249937"
        },
        other {
          db "ELocationID doi",
          tag str "10.1126/science.1149200"
        }
      }
    },
    abstract "Retroviral short hairpin RNA (shRNA)-mediated genetic screens in
 mammalian cells are powerful tools for discovering loss-of-function
 phenotypes. We describe a highly parallel multiplex methodology for screening
 large pools of shRNAs using half-hairpin barcodes for microarray
 deconvolution. We carried out dropout screens for shRNAs that affect cell
 proliferation and viability in cancer cells and normal cells. We identified
 many shRNAs to be antiproliferative that target core cellular processes, such
 as the cell cycle and protein translation, in all cells examined. Moreover,
 we identified genes that are selectively required for proliferation and
 survival in different cell lines. Our platform enables rapid and
 cost-effective genome-wide screens to identify cancer proliferation and
 survival genes for target discovery. Such efforts are complementary to the
 Cancer Genome Atlas and provide an alternative functional view of cancer
 cells.",
    mesh {
      {
        term "Breast Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Cell Line"
      },
      {
        term "Cell Line, Tumor"
      },
      {
        mp TRUE,
        term "Cell Proliferation"
      },
      {
        term "Cell Survival",
        qual {
          {
            subh "genetics"
          }
        }
      },
      {
        term "Colonic Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Gene Library"
      },
      {
        mp TRUE,
        term "Genes, Neoplasm"
      },
      {
        term "Genetic Vectors"
      },
      {
        term "Genome, Human"
      },
      {
        term "Genomics",
        qual {
          {
            mp TRUE,
            subh "methods"
          }
        }
      },
      {
        term "Humans"
      },
      {
        term "MicroRNAs"
      },
      {
        term "Oligonucleotide Array Sequence Analysis"
      },
      {
        term "RNA, Small Interfering"
      },
      {
        term "Retroviridae",
        qual {
          {
            subh "genetics"
          }
        }
      }
    },
    substance {
      {
        type nameonly,
        name "MicroRNAs"
      },
      {
        type nameonly,
        name "RNA, Small Interfering"
      }
    },
    idnum {
      "F31 NS054507-01/NS/NINDS NIH HHS",
      "P01 CA013106/CA/NCI NIH HHS",
      "P01 CA013106-36/CA/NCI NIH HHS",
      "P01 CA013106-37/CA/NCI NIH HHS",
      "R01 AG011085/AG/NIA NIH HHS",
      "T32CA09216/CA/NCI NIH HHS",
      "Howard Hughes Medical Institute"
    },
    pmid 18239126,
    pub-type {
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't",
      "Research Support, U.S. Gov't, Non-P.H.S."
    },
    status medline
  }
}



Pubmed-entry ::= {
  pmid 18239125,
  medent {
    em std {
      year 2008,
      month 2,
      day 1
    },
    cit {
      title {
        name "Profiling essential genes in human mammary cells by multiplex
 RNAi screening."
      },
      authors {
        names std {
          {
            name ml "Silva JM",
            affil str "Watson School of Biological Sciences, Howard Hughes
 Medical Institute, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
 11724, USA."
          },
          {
            name ml "Marran K"
          },
          {
            name ml "Parker JS"
          },
          {
            name ml "Silva J"
          },
          {
            name ml "Golding M"
          },
          {
            name ml "Schlabach MR"
          },
          {
            name ml "Elledge SJ"
          },
          {
            name ml "Hannon GJ"
          },
          {
            name ml "Chang K"
          }
        }
      },
      from journal {
        title {
          iso-jta "Science",
          ml-jta "Science",
          issn "1095-9203",
          name "Science (New York, N.Y.)"
        },
        imp {
          date std {
            year 2008,
            month 2,
            day 1
          },
          volume "319",
          issue "5863",
          pages "617-620",
          language "eng",
          pubstatus ppublish,
          history {
            {
              pubstatus pubmed,
              date std {
                year 2008,
                month 2,
                day 2,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus medline,
              date std {
                year 2008,
                month 2,
                day 13,
                hour 9,
                minute 0
              }
            },
            {
              pubstatus other,
              date std {
                year 2008,
                month 2,
                day 2,
                hour 9,
                minute 0
              }
            }
          }
        }
      },
      ids {
        pii "319/5863/617",
        doi "10.1126/science.1149185",
        pubmed 18239125,
        other {
          db "pmc",
          tag str "PMC2981861"
        },
        other {
          db "mid",
          tag str "NIHMS249659"
        },
        other {
          db "ELocationID doi",
          tag str "10.1126/science.1149185"
        }
      }
    },
    abstract "By virtue of their accumulated genetic alterations, tumor cells
 may acquire vulnerabilities that create opportunities for therapeutic
 intervention. We have devised a massively parallel strategy for screening
 short hairpin RNA (shRNA) collections for stable loss-of-function phenotypes.
 We assayed from 6000 to 20,000 shRNAs simultaneously to identify genes
 important for the proliferation and survival of five cell lines derived from
 human mammary tissue. Lethal shRNAs common to these cell lines targeted many
 known cell-cycle regulatory networks. Cell line-specific sensitivities to
 suppression of protein complexes and biological pathways also emerged, and
 these could be validated by RNA interference (RNAi) and pharmacologically.
 These studies establish a practical platform for genome-scale screening of
 complex phenotypes in mammalian cells and demonstrate that RNAi can be used
 to expose genotype-specific sensitivities.",
    mesh {
      {
        term "Breast",
        qual {
          {
            mp TRUE,
            subh "cytology"
          },
          {
            mp TRUE,
            subh "metabolism"
          }
        }
      },
      {
        term "Breast Neoplasms",
        qual {
          {
            mp TRUE,
            subh "genetics"
          },
          {
            subh "pathology"
          }
        }
      },
      {
        term "Cell Line"
      },
      {
        term "Cell Line, Tumor"
      },
      {
        mp TRUE,
        term "Cell Proliferation"
      },
      {
        mp TRUE,
        term "Cell Survival"
      },
      {
        term "Gene Expression Profiling"
      },
      {
        mp TRUE,
        term "Genes, Essential"
      },
      {
        term "Genomics"
      },
      {
        term "Humans"
      },
      {
        term "Metabolic Networks and Pathways",
        qual {
          {
            mp TRUE,
            subh "genetics"
          }
        }
      },
      {
        term "Oligonucleotide Array Sequence Analysis"
      },
      {
        term "Phenotype"
      },
      {
        mp TRUE,
        term "RNA Interference"
      },
      {
        term "RNA, Small Interfering"
      }
    },
    substance {
      {
        type nameonly,
        name "RNA, Small Interfering"
      }
    },
    idnum {
      "P01 CA013106/CA/NCI NIH HHS",
      "P01 CA013106-36/CA/NCI NIH HHS",
      "P01 CA013106-37/CA/NCI NIH HHS",
      "Howard Hughes Medical Institute"
    },
    pmid 18239125,
    pub-type {
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, U.S. Gov't, Non-P.H.S."
    },
    status medline
  }
}


